Info

ChiRhoClin, Inc., a Maryland based corporation, was founded in 1991 by CEO, Edward D. Purich, Ph.D. ChiRhoClin is a research and development oriented pharmaceutical company focused on the development of peptide and protein based drug products. ChiRhoClin, Inc also provides contract services to the pharmaceutical industry in areas including regulatory support, clinical and medical monitoring, report writing, safety surveillance, pharmacokinetics, pharmacodynamics and biostatistics. ChiRhoClin received approval from the FDA on April 5th, 2002 to manufacture and market Synthetic Porcine Secretin. Two years later, ChiRhoClin received approval from the FDA on April 9th, 2004 to manufacture and market Synthetic Human Secretin. ChiRhoClin mission is to develop high quality peptide and protein based drug products.